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Isopenicillin-N synthetase (IPNS) was purified to homogeneity from Cephalosporium acremonium C0728. 
The enzyme existed in two states during purification; an oxidised state with a disulphide linkage and its 
reduced state. These two forms can he interconverted in the presence or absence of thiol agents, and separat- 
ed by fast protein liquid chromatography (FPLC) with the strong anion exchange Mono-Q column. The 
enzyme is a monomer with a molecular mass of 38 kDa and ~15.05. The first 50 amino acid N-terminal 
sequence of the enzyme was determined. The purified enzyme has an absolute requirement of Fe*+ and a 
2-electron donor for activity. 
Cephalosporium Isopenicillin-N synthetase Amino acid sequence 
1. INTRODUCTION 2. MATERIALS AND METHODS 
IPNS catalyses the cyclization of the tripeptide 
&(L-cY-aminoadipyl)-L-cysteinyl-D-valine to iso- 
penicillin-N in the presence of oxygen, Fe*+ and 
ascorbate [l]. Formation of isopenicillin-N in this 
reaction is a step common to the biosynthesis of all 
penicillin and cephalosporin antibiotics. This en- 
zyme has been partially purified from the fl-lactam 
antibiotic producing microorganisms Cephalo- 
sporium acremonium, Penicillium chrysogenum 
and Streptomyces clavuligerus [2,3,8]. Here, we 
report for the first time the appearance of two 
states of the enzyme due to reduction and forma- 
tion of an intramolecular disulphide bond, and its 
N-terminal amino acid sequence of 50 residues. 
Preliminary characterisation and some properties 
of the enzyme are also reported. 
&(L-cY-Aminoadipyl)-L-cysteinyl-D-valine was 
prepared according to Baldwin et al. [4]. C. 
acremonium CO728 was a gift from Glaxo, Ulver- 
ston, England. Mono Q 5/5 anion exchange and 
Superose 12 columns were obtained from Phar- 
macia, Uppsala. All other chemicals were of the 
highest purity available. Glass distilled water was 
used throughout. 
Abbreviations: IPNS, isopenicillin-N synthetase; 
FPLC, fast protein liquid chromatography; SDS- 
PAGE, SDS-polyacrylamide gel electrophoresis 
The growth of C. acremonium and initial stages 
of purification were carried out in a similar pro- 
cedure according to [2] with several modifications. 
The phenyl-Sepharose step was substituted by gel 
filtration with a Sephadex G-75 column because of 
low recovery of enzyme activity after the hydro- 
phobic chromatography (< 50%). Tris-HCl buffer 
(50 mM, pH 7.7) was used throughout. In the final 
stage, the desalted enzyme obtained after DEAE- 
Sepharose was mixed with 10 mM 2-mercapto- 
ethanol for 10 min at 4°C before 4 mg of the pro- 
tein sample was loaded onto a Mono Q 5/5 strong 
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anion exchange column for FPLC (Pharmacia). 
IPNS was eluted under a linear gradient of NaCl 
(SO-150 mM) in 20 mM Tris-HCI buffer (pH 8.0). 
Enzyme activity was assayed in 50 mM Tris-HCI 
(pH 7.7) according to [2], and the purified enzyme 
sample was assayed by a couple-enzyme assay 
method described in [5]. 
Automated Edman degradation was performed 
in a Beckman 890C sequencer according to Christie 
and Gagnon [6], and the amino acid composition 
analysis was carried out with an LKB 4400 (LKB 
Biochrom, Sweden) automated amino acid ana- 
lyser. SDS-PAGE was performed as described by 
Laemmli [7] on 14% acrylamide gel slabs and 
isoelectric focusing was carried out as in [2]. 
3. RESULTS AND DISCUSSION 
In the final stage of purification with FPLC, we 
b 
found that most of the enzyme activity co-ran with 
2 major contaminants in an earlier peak before 
preincubation with thiol reagents. However, after 
treatment with 2-mercaptoethanol the IPNS was 
eluted in a later peak and separated from the major 
contaminants (fig. 1). This purified protein was 
judged to be homogeneous by SDS-PAGE and 
isoelectric focusing (figs 2,3). It has a molecular 
mass of 45 kDa by gel filtration analysis and 38 
kDa by SDS-PAGE. Isoelectric focusing shows 
that it has a pl of 5.05. 
The observation of 2, chromatographically 
distinct, forms of the same enzyme was probably 
due to the reduction of an intramolecular disul- 
phide bond since both forms have the same mole- 
cular mass (s 45 kDa) when determined by FPLC- 
Superose gel filtration analysis against molecular 
mass markers. The reduced form of the enzyme 
was converted back to the oxidised form during 
storage at 4°C as judged by the elution profile on 
FPLC. When IPNS freshly prepared in the re- 
b IPNS reduced state 
ELUTION TIME lm,n I 
Fig. 1. FPLC of IPNS: (A) before treatment with 10 mM 
mercaptoethanol and (B) after treatment with 10 mM 
mercaptoethanol. (-) Absorbance at 280 nM, (- - -) 
NaCl gradient. For details see text. 
Fig.2. SDS-PAGE of IPNS; (a) molecular mass 
markers, (b) oxidised form and (c) reduced form. The 
oxidised form was obtained by FPLC of the reduced 
form which had been left at 4°C overnight. 
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Fig.3. Isoelectric focusing of (a) IPNS and (b) Phar- 
macia protein pl markers in the range ~13-10. 
duced form was titrated with 5,5’-dithiobis(2- 
nitrobenzoic acid) (DTNB) it gave 2 equivalents of 
-SH groups under native conditions and a value of 
2.6 in the presence of 6 M guanidinium chloride. 
The oxidised form of the enzyme obtained by 
FPLC after storage at 4°C overnight in air did not 
Table 1 
Effect of some common 2-electron donors on IPNS 
activity 
2-electron donors Relative activity (vo) 
None 
Ascorbic acid 
D-Isoascorbic acid 
Alloxan 
Dihydroxyfumaric acid 
2,4,5-Triamino-6-hydroxy- 
pyrimidine 
0 
100 
120 
0 
25 
0 
All were tested at 1 mM with 2.73 x lo-* IU of enzyme 
by bioassay 
Table 2 
Amino acid composition of IPNS (mol/mol enzyme, M, 
= 38000) 
Amino Acids A B 
CYs _ 3 
Asp 36 36 
Thr 15 14 
Ser 15 17 
Glu 31 32 
Pro 23 22 
GlY 28 19 
Ala 29 26 
Val 22 21 
Met 4 4 
Be 15 16 
Leu 24 25 
Tyr 15 8 
Phe 15 15 
His 8 10 
LYS 20 19 
Arg 15 19 
(A) Results from acid hydrolysis alone and (B) results 
obtained after performic acid oxidation and then acid 
hydrolysis 
show a titratable thiol group under non-denaturing 
conditions, and gave result of 0.8 equivalent of - 
SH when titrated in the presence of 6 M guanidi- 
nium chloride. This further substantiates the view 
that an easily accessible intramolecular disulphide 
bond is the difference between these two forms of 
the enzyme. 
The purified IPNS has an absorption maximum 
at 278 nm with a shoulder at 290 nm. The absor- 
bance ratio of 280/260 nm is 1.98. It has no ab- 
sorption in the spectral region 320-900 nm. This 
enzyme has an absolute requirement of Fe’+ for 
activity. It also requires ascorbate for activity. 
Dihydroxyfumarate could replace ascorbate with 
25% efficiency at the same concentration. Other 
common 2-electron donors have no effect when 
tested under the same conditions (table 1). The 
specific activity of the purified IPNS obtained here 
was 2.73 IU/mg protein when determined by 
bioassay. The purified enzyme is stable at -70°C 
in freeze-dried form and unstable when kept at 
4°C in 20 mM Tris-HCl buffer (pH 8.0). 
The results of the amino acid composition 
analysis of the homogeneous IPNS with and 
without performic acid oxidative pretreatment are 
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Volume 188, number 2 FEBS LETTERS 
Table 3 
September 1985 
N-terminal amino acid sequence of IPNS from Cephalosporium acremonium CO728 
shown in table 2. The first 50 N-terminal amino 
acid sequence is shown in table 3. The purified 
IPNS and its amino acid sequence reported here 
has been supplied to other groups for raising 
monoclonal antibodies and cloning of the IPNS 
gene. 
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